Research & Papers

VesselSim achieves zero-shot blood vessel segmentation without annotations

Medical image segmentation has long been bottlenecked by the need for expert annotations—VesselSim shows it’s possible to achieve competitive results without a single real label.

Deep Dive

Blood vessel segmentation is critical for vascular disease care and surgical planning, but obtaining expert annotations for deep learning training remains a major bottleneck. To address this, researchers introduce VesselSim, a two-stage framework that removes the need for real annotated data. First, a stochastic, geometry-driven simulation models recursive branching, curvature-controlled growth, and collision-aware topology, combined with domain-randomized intensity synthesis to produce 16,500 anatomically plausible 3D angiographic volumes. Second, a 3D U-Net is trained exclusively on this synthetic data. To bridge the domain gap at inference time, a test-time adaptation strategy uses a self-supervised mask reconstruction decoder, enabling adaptation to unseen clinical scans without prior domain knowledge.

VesselSim was evaluated in a zero-shot setting on multiple real-world datasets spanning MR and CT across brain and kidney regions. Despite having never seen real medical images during training, its performance is competitive with state-of-the-art vascular segmentation foundation models. These findings suggest that learning vessel geometry from synthetic tubular structures generalizes robustly across domains, substantially reducing reliance on acquired medical imaging data and, critically, expert annotations. The work will be presented at MICCAI 2026 and is currently available on arXiv.

Key Points
  • VesselSim achieves zero-shot 3D blood vessel segmentation using 16,500 synthetic volumes, eliminating the need for expert annotations.
  • Its dice scores on brain and kidney datasets rival supervised methods but have not been validated on coronary, retinal, or hepatic vessels.
  • The approach highlights the potential of synthetic data to reduce annotation costs, but pathological variations and domain gaps remain unsolved hurdles.

Why It Matters

Synthetic data could cut annotation costs in medical imaging, but clinical validation on diverse pathologies is essential.

📬 Get the top 10 AI stories daily